NORBERTO
ORTEGO CENTENO
CATEDRÁTICO DE UNIVERSIDAD
Vicent
Fonollosa Pla
Publicaciones en las que colabora con Vicent Fonollosa Pla (45)
2024
2023
-
External clinical validation of automated software to identify structural abnormalities and microhaemorrhages in nailfold videocapillaroscopy images
Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1605-1611
-
Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival
Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1695-1703
2022
-
Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature
Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E180-E188
-
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)
Scientific Reports
-
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Scientific reports, Vol. 12, Núm. 1, pp. 5289
-
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry
Seminars in Arthritis and Rheumatism, Vol. 55
-
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)
Autoimmunity Reviews, Vol. 21, Núm. 10
2021
-
Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))
Autoimmunity Reviews
-
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)
Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Longterm efficacy and safety of monotherapy versus combination therapy in systemic sclerosis-associated pulmonary arterial hypertension: A retrospective RESCLE registry study
Journal of Rheumatology, Vol. 47, Núm. 1, pp. 89-98
-
Nailfold capillaroscopy in the Spanish Group of Systemic Autoimmune Diseases (GEAS). Results of an electronic survey
Medicina Clinica, Vol. 155, Núm. 11, pp. 509-510
-
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Autoimmunity Reviews, Vol. 19, Núm. 5
2019
-
Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry
Clinical Rheumatology, Vol. 38, Núm. 4, pp. 1117-1124
2018
-
Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study (Clinical Rheumatology, (2018), 37, 4, (999-1009), 10.1007/s10067-017-3936-7)
Clinical Rheumatology
-
First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study
Clinical Rheumatology, Vol. 37, Núm. 4, pp. 999-1009
-
Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry
Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 6, pp. 849-857
-
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group
Rheumatology International, Vol. 38, Núm. 3, pp. 363-374
2017
-
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)
Clinical and Experimental Rheumatology, Vol. 35, pp. S40-S47